• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Edgewell Personal Care Announces Third Quarter Fiscal 2023 Results

    8/3/23 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $EPC alert in real time by email

    Net Sales Increase of 4.2%, or 4.5% Organic

    GAAP EPS growth of 77%,  Adjusted EPS Growth of 14% or 22% at Constant Currency

    Meaningful Gross Margin Accretion

    Updates Full Year Outlook

    SHELTON, Conn., Aug. 3, 2023 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its third fiscal quarter 2023 ended June 30, 2023. 

    Edgewell Personal Care Company logo (PRNewsFoto/Edgewell Personal Care Company)

    Executive Summary

    • Net sales were $650.0 million, an increase of 4.2% compared to the prior year quarter.
    • Organic net sales increased 4.5% (Organic basis excludes the unfavorable impact from currency movements.)
    • GAAP Diluted net Earnings Per Share ("EPS") were $1.01 for the third fiscal quarter compared to $0.57 in the prior year quarter.
    • Adjusted EPS were $0.98, inclusive of a $0.09 unfavorable impact from currency movements, compared to $0.86 in the prior year quarter.
    • Ended the third fiscal quarter with $207.4 million in cash on hand, access to an additional $334.1 million revolving credit facility and a net debt leverage ratio of 3.2x.
    • Returned $22.9 million to shareholders in the form of $15.2 million in share repurchases and $7.7 million of dividends in the third fiscal quarter.
    • Board of Directors declared a cash dividend of $0.15 per common share on August 1, 2023 for the third fiscal quarter.
    • On track to deliver organic net sales growth slightly above the mid-point, adjusted EPS at the high-end, and adjusted EBITDA slightly above the high-end of the previously provided ranges.

    The Company reports and forecasts results on a GAAP and non-GAAP basis and has reconciled non-GAAP results and outlook to the most directly comparable GAAP measures later in this release.  See non-GAAP Financial Measures for a more detailed explanation, including definitions of various non-GAAP terms used in this release.  All comparisons used in this release are with the same period in the prior fiscal year unless otherwise stated.

    "Our results this quarter continued to demonstrate the success of our transformation, as we delivered strong organic net sales and earnings per share growth, expanded gross margin and generated substantial cash," said Rod Little, Edgewell's President and Chief Executive Officer.  "These results reflect the underlying strength of our business, our broad portfolio of consumer centric brands, and the breadth of our global business.  While the macro environment remains uncertain, and our Sun Care business has been impacted by unfavorable weather, we are on track to deliver our third consecutive year of 4% organic net sales growth, and Adjusted EPS and Adjusted EBITDA at or above the high end of our previously provided outlook ranges.  Notably, we remain focused on executing against our strategic priorities which position us to deliver sustained growth and value creation." 

    Fiscal 3Q 2023 Operating Results (Unaudited)

    Net sales were $650.0 million in the quarter, an increase of 4.2%, including a $1.7 million unfavorable impact from currency movements.  Organic net sales increased 4.5%, as international markets increased 8.7%, driven by strong Wet Shave, Sun Care and Grooming performance and North America markets increased 2.3%, driven by Sun Care and Grooming growth.  In aggregate, growth in organic net sales was driven by increased pricing.

    Gross profit was $279.7 million, inclusive of a $7.2 million unfavorable impact from currency movements, as compared to $240.6 million in the prior year quarter. Gross margin as a percent of net sales was 43.0%, an increase of 440-basis points compared to the prior year period. Adjusted gross margin increased 80-basis points, or 185-basis points at constant currency, as productivity savings of approximately 205-basis points, and the benefit of higher pricing of 375-basis points, more than offset gross inflationary pressures of approximately 330-basis points and negative mix.

    Advertising and sales promotion expense ("A&P") was $80.0 million, or 12.3% of net sales, a decrease of $0.9 million, compared to $80.9 million, or 13.0% of net sales in the prior year quarter.    

    Selling, general and administrative expense ("SG&A") was $96.3 million, or 14.8% of net sales, as compared to $92.7 million, or 14.9% of net sales in the prior year quarter. Adjusted SG&A as a percent of net sales decreased 20-basis points as the benefits of leverage and operational efficiency programs more than offset the impact of higher people costs and travel expense.

    The Company recorded pre-tax restructuring expenses of $3.1 million in the quarter, consisting largely of severance and outplacement costs in support of cost efficiency programs, $1.0 million in acquisition and integration costs related to the Billie acquisition, and recorded a $6.8 million net benefit related to favorable resolution of legal matters.

    Operating income, was $85.6 million, inclusive of a $6.7 million unfavorable impact from currency movements, compared to $49.9 million in the prior year quarter. Adjusted operating income increased 18.8% to $83.5 million, or 12.8% of net sales, compared to $70.3 million, or 11.3% of net sales in the prior year quarter.  Adjusted operating margins increased 150-basis points, or 250-basis points at constant currency, driven by operational leverage and improved gross margins.      

    Interest expense associated with debt was $19.2 million, compared to $18.0 million in the prior year period. The increase in interest expense was the result of higher interest rates and a higher overall debt balance on the Company's revolving credit facility.

    Other expense (income), net was income of $3.8 million compared to $4.4 million of income in the prior year quarter.

    The effective tax rate for the first nine months of fiscal 2023 was 25.9% compared to 18.5% in the prior year period.  The adjusted effective tax rate for the first nine months of fiscal 2023 was 25.9%, up from the prior year period adjusted effective tax rate of 20.0%.  The fiscal 2023 adjusted effective tax rate reflects an unfavorable mix of earnings in higher tax rate jurisdictions compared to prior year. In addition, fiscal 2022 includes the favorable impact of a change in the Company's prior estimates.

    GAAP net earnings were $52.5 million or $1.01 per diluted share compared to $30.5 million or $0.57 per diluted share in the third quarter of fiscal 2022. Adjusted net earnings were $50.8 million or $0.98 per share, inclusive of a $0.09 unfavorable impact from currency movements, compared to $45.8 million or $0.86 per share in the prior year quarter.  Adjusted EBITDA was $109.1 million, inclusive of a $5.5 million unfavorable currency impact, compared to $97.1 million in the prior year quarter. 

    Net cash from operating activities was $168.3 million for the nine months ending June 30, 2023 compared to $72.4 million in the prior year period. The increase in cash from operating activities was driven by favorable changes in working capital and increased earnings.

    Capital Allocation

    On August 1, 2023, the Board of Directors declared a quarterly cash dividend of $0.15 per common share for the third fiscal quarter. The dividend will be payable on October 4, 2023 to shareholders of record as of the close of business on September 7, 2023.  During the third quarter of fiscal 2023, the Company paid dividends totaling $7.7 million to stockholders.

    During the third quarter of fiscal 2023, the Company completed share repurchases of approximately 0.3 million shares at a total cost of $15.2 million. As of June 30, 2023 the Company had 5.4 million shares of common stock available for repurchase in the future under the Board's 2018 authorization.

    Fiscal 3Q 2023 Operating Segment Results (Unaudited)

    Wet Shave (Men's Systems, Women's Systems, Disposables, and Shave Preps)

    Net sales decreased $2.2 million, or 0.7%. Organic net sales decreased $0.2 million or 0.1%, as the benefit of higher pricing was offset by lower volumes.  Growth in Men's Systems and Disposable's was offset by declines in Shave Preps and Women's Systems.  Wet Shave segment profit decreased $5.4 million, or 14.4%. Organic segment profit, excluding the unfavorable impact from currency increased $1.2 million, or 3.2%, reflecting higher gross profit, partly offset by higher marketing expense.

    Sun and Skin Care (Sun Care, Wet Ones, Bulldog, Jack Black and Cremo)

    Net sales increased $28.7 million, or 13.3%.  Organic net sales increased $28.1 million, or 13.0%, driven by strong growth across Sun Care, Men's Grooming and Wet One's.  Organic net sales in International markets increased 21.0%, led by strong Sun Care demand in Latin America and Europe and higher pricing, while in North America, organic net sales increased 11.3%, driven by price and volume gains.  Segment profit increased $14.5 million, or 31.1%. Organic segment profit increased $14.7 million, or 31.5%, primarily driven by higher organic net sales and gross profit and lower marketing expense.

    Feminine Care (Tampons, Pads, and Liners)

    Net sales decreased $0.3 million, or 0.4%.  Organic net sales were in-line with prior year, reflecting lower volumes, offset by higher pricing.  Segment profit increased $5.1 million. Organic segment profit increased $5.2 million, or 59.1%, primarily driven by higher gross margin.

    Full Fiscal Year 2023 Financial Outlook

    The Company is providing the following updated outlook assumptions for fiscal 2023:

    • Reported net sales are expected to increase slightly above the mid-point of the the range of 2% to 4%.
      • Includes an estimated 60-basis point inorganic benefit in net sales from the acquisition of Billie, net of prior year Edgewell sales to Billie and an estimated 120-basis point (previously 115-basis point) negative impact from currency movements
    • Organic net sales are now expected to increase slightly above the mid-point of the range of 3% to 5% (previously high end of the range)
    • GAAP EPS is now expected to be in the range of $1.95 to $2.15 (previously $1.80 to $2.00)
      • Includes: Restructuring charges*, acquisition and integration costs, Sun Care reformulation costs, Canadian Pension wind-up costs, and favorable resolution of legal matters
    • Adjusted EPS is now expected to be at the high end of the range of $2.30 to $2.50
      • Includes an estimated $0.38 EPS (previously $0.43) unfavorable impact from foreign currency movements
      • Gross margin is now expected to be flat to the prior year (previously 30-basis point increase)
      • Operating margin is expected to increase slightly
      • The EPS outlook reflects the impact of estimated share repurchases
    • Adjusted EBITDA is now expected to be slightly above the high end of the range of $320 to $335 million
      • Includes an estimated $26 million (previously $29 million) unfavorable impact from foreign currency changes
    • Adjusted effective tax rate is expected to be approximately 25%
    • Free cash flow is now expected to be approximately $150 million (previously $140 million)

    * In fiscal 2023, the Company is taking specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency.  As a result of these actions, the Company expects to incur charges of approximately $18 million for the full fiscal year.

    Webcast Information

    In conjunction with this announcement, the Company will hold an investor conference call beginning at 8:00 a.m. Eastern Time today. All interested parties may access a live webcast of this conference call at www.edgewell.com, under the "Investors," and "News and Events" tabs or by using the following link:  http://ir.edgewell.com/news-and-events/events

    For those unable to participate during the live webcast, a replay will be available on www.edgewell.com, under the "Investors," "Financial Reports," and "Quarterly Earnings" tabs.  This release includes references to the Company's website and references to additional information and materials found on its website. The Company's website and such information and materials are not incorporated by reference in, and are not part of, this release.

    About Edgewell

    Edgewell is a leading pure-play consumer products company with an attractive, diversified portfolio of established brand names such as Schick®, Wilkinson Sword® and Billie® men's and women's shaving systems and disposable razors; Edge and Skintimate® shave preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine care products; Banana Boat®, Hawaiian Tropic®, Bulldog®,  Jack Black®, and CREMO® sun and skin care products; and Wet Ones® products. The Company has a broad global footprint and operates in more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 7,000 employees worldwide.

    Forward-Looking Statements. This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. Forward-looking statements generally can be identified by the use of words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "will," "should," "forecast," "outlook," or other similar words or phrases. These statements are not based on historical facts, but instead reflect the Company's expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings and performance of Edgewell or any of its businesses. Many factors outside our control could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause the Company's actual results to differ materially from those indicated by those statements. The Company cannot assure you that any of its expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and the Company disclaims any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law.  You should not place undue reliance on these statements.

    In addition, other risks and uncertainties not presently known to the Company or that it presently considers immaterial could significantly affect the accuracy of any such forward-looking statements. Risks and uncertainties include those detailed from time to time in the Company's publicly filed documents, including in Item 1A. Risk Factors of Part I of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 16, 2022.

    Non-GAAP Financial Measures. While the Company reports financial results in accordance with generally accepted accounting principles ("GAAP") in the U.S., this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as "adjusted" or "organic" and exclude items such as restructuring and related costs, acquisition and integration costs, Sun Care reformulation costs, value-added tax ("VAT") settlement costs, loss on defined benefit settlement, income from resolution of legal matters, and other costs or income. Reconciliations of non-GAAP measures, including reconciliations of measures related to the Company's fiscal 2023 financial outlook, are included within the Notes to Condensed Consolidated Financial Statements included with this release.

    This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. The Company uses this non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is a component in determining management's incentive compensation. Finally, the Company believes this information provides a higher degree of transparency. The following provides additional detail on the Company's non-GAAP measures:

    • The Company utilizes "adjusted" non-GAAP measures including gross profit, SG&A, operating income, income taxes, net earnings, diluted earnings per share, and EBITDA to internally make operating decisions. The following items are excluded when analyzing non-GAAP measures: restructuring and related costs, acquisition and integration costs, Sun Care reformulation costs, VAT settlement costs, loss on defined benefit settlement, stock keeping unit ("SKU") rationalization charges, income from resolution of legal matters and at times management excludes other costs and income.
      • Constant currency measures are calculated by removing the impact of translational and transactional foreign currencies changes net of foreign currency hedges compared to the prior year. Transactional foreign currency changes are driven by foreign legal entities transactions not denominated in local currency.
    • The Company analyzes its net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency and the impact of acquisitions.
      • Organic net sales was unfavorably impacted in October and November of fiscal 2023 by the Billie acquisition as sales that were previously reported as third party sales to Billie are now included as inter-company sales.
      • Segment profit will be impacted by fluctuations in translation and transactional foreign currency. The impact of currency was applied to segments using management's best estimate.
    • Free cash flow is defined as net cash from operating activities less capital expenditures plus collections of deferred purchase price of accounts receivable sold and proceeds from sales of fixed assets. Free cash flow conversion is defined as free cash flow as a percentage of net earnings adjusted for the net impact of non-cash impairments.
    • Net debt defined as total debt less cash. Net debt ratio is defined as total debt less cash divided by trailing twelve month adjusted EBITDA.

     

    EDGEWELL PERSONAL CARE COMPANY

    CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

    (unaudited, in millions, except per share data)





    Three Months Ended

    June 30,



    Nine Months Ended

    June 30,



    2023



    2022



    2023



    2022

    Net sales

    $             650.0



    $             623.8



    $          1,717.5



    $          1,634.8

    Cost of products sold

    370.3



    383.2



    1,007.1



    974.2

    Gross profit

    279.7



    240.6



    710.4



    660.6

















    Selling, general and administrative expense

    96.3



    92.7



    297.2



    290.9

    Advertising and sales promotion expense

    80.0



    80.9



    188.8



    197.0

    Research and development expense

    14.8



    13.6



    42.6



    40.1

    Restructuring charges

    3.0



    3.5



    8.7



    9.2

    Operating income

    85.6



    49.9



    173.1



    123.4

    Interest expense associated with debt

    19.2



    18.0



    59.8



    53.3

    Other (income) expense, net

    (3.8)



    (4.4)



    0.7



    (9.5)

    Earnings before income taxes

    70.2



    36.3



    112.6



    79.6

    Income tax provision

    17.7



    5.8



    29.2



    14.7

    Net earnings

    $               52.5



    $               30.5



    $               83.4



    $               64.9

















    Earnings per share:















        Basic net earnings per share

    $               1.03



    $               0.58



    $               1.62



    $               1.21

        Diluted net earnings per diluted share

    $               1.01



    $               0.57



    $               1.61



    $               1.20

















    Weighted-average shares outstanding:















         Basic

    51.1



    52.5



    51.3



    53.5

         Diluted

    51.8



    53.1



    51.9



    54.1

















    See Accompanying Notes.

     

    EDGEWELL PERSONAL CARE COMPANY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (unaudited, in millions)  





    June 30,

    2023



    September 30,

    2022

    Assets







    Current assets







    Cash and cash equivalents

    $               207.4



    $               188.7

    Trade receivables, less allowance for doubtful accounts

    121.5



    136.9

    Inventories

    502.5



    449.3

    Other current assets

    157.2



    167.3

    Total current assets

    988.6



    942.2

    Property, plant and equipment, net

    339.8



    345.5

    Goodwill

    1,336.1



    1,322.2

    Other intangible assets, net

    983.7



    996.6

    Other assets

    118.1



    106.6

    Total assets

    $            3,766.3



    $            3,713.1









    Liabilities and Shareholders' Equity







    Current liabilities







    Notes payable

    $                 17.7



    $                 19.0

    Accounts payable

    241.1



    237.3

    Other current liabilities

    321.0



    291.7

    Total current liabilities

    579.8



    548.0

    Long-term debt

    1,323.1



    1,391.4

    Deferred income tax liabilities

    142.3



    140.4

    Other liabilities

    170.0



    173.6

    Total liabilities

    2,215.2



    2,253.4

    Shareholders' equity







    Common shares

    0.7



    0.7

    Additional paid-in capital

    1,586.3



    1,604.3

    Retained earnings

    991.2



    931.7

    Common shares in treasury at cost

    (876.3)



    (860.9)

    Accumulated other comprehensive loss

    (150.8)



    (216.1)

    Total shareholders' equity

    1,551.1



    1,459.7

    Total liabilities and shareholders' equity

    $            3,766.3



    $            3,713.1









    See Accompanying Notes.

     

    EDGEWELL PERSONAL CARE COMPANY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (unaudited, in millions)





    Nine Months Ended

    June 30,



    2023



    2022

    Cash Flow from Operating Activities







    Net earnings

    $               83.4



    $               64.9

    Depreciation and amortization

    68.1



    67.1

    Share-based compensation expense

    19.8



    18.4

    Loss on sale of assets

    1.1



    0.6

    Defined benefit settlement loss

    7.2



    —

    Deferred compensation payments

    (4.9)



    (7.1)

    Deferred income taxes

    (0.6)



    (10.6)

    Other, net

    (13.6)



    (4.8)

    Changes in operating assets and liabilities

    7.8



    (56.1)

    Net cash from operating activities

    $             168.3



    $               72.4









    Cash Flow from Investing Activities







    Capital expenditures

    $             (31.1)



    $             (37.4)

    Acquisition of Billie, net of cash acquired

    —



    (309.4)

    Collection of deferred purchase price on accounts receivable sold

    1.5



    5.6

    Proceeds from sale of Infant and Pet Care business

    —



    5.0

    Other, net

    (2.0)



    (1.4)

    Net cash used by investing activities

    $             (31.6)



    $           (337.6)









    Cash Flow from Financing Activities







    Cash proceeds from debt with original maturities greater than 90 days

    $             645.0



    $             534.0

    Cash payments on debt with original maturities greater than 90 days

    (715.0)



    (413.0)

    Proceeds (payments) of debt with original maturities of 90 days or less

    5.1



    (4.3)

    Repurchase of shares

    (45.2)



    (110.1)

    Dividends to common shareholders

    (23.8)



    (24.7)

    Net financing inflow from the Accounts Receivable Facility

    9.6



    6.5

    Employee shares withheld for taxes

    (9.0)



    (10.4)

    Other, net

    1.0



    0.6

    Net cash used by financing activities

    $           (132.3)



    $             (21.4)









    Effect of exchange rate changes on cash

    14.3



    (11.0)









    Net increase (decrease) in cash and cash equivalents

    18.7



    (297.6)

    Cash and cash equivalents, beginning of period

    188.7



    479.2

    Cash and cash equivalents, end of period

    $             207.4



    $             181.6



    See Accompanying Notes.

     

    EDGEWELL PERSONAL CARE COMPANY

    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

    (unaudited, in millions, except per share data)

    Note 1 —  Segments

    The Company conducts its business in the following three segments: Wet Shave, Sun and Skin Care, and Feminine Care (collectively, the "Segments," and each individually, a "Segment"). Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, restructuring and related costs, and may at times include other costs or income, including acquisition and integration costs, Sun Care reformulation costs, value-added tax ("VAT") settlement costs, the loss on the Canadian defined benefit settlement, income from resolution of legal matters, stock keeping unit ("SKU") rationalization charges and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.

    The Company completed the acquisition of Billie on November 29, 2021.

    Segment net sales and profitability are presented below:



    Three Months Ended

    June 30,



    Nine Months Ended

    June 30,



    2023



    2022



    2023



    2022

    Net Sales















    Wet Shave

    $             324.1



    $             326.3



    $          908.0



    $             917.4

    Sun and Skin Care

    244.9



    216.2



    567.5



    504.3

    Feminine Care

    81.0



    81.3



    242.0



    213.1

    Total net sales

    $             650.0



    $             623.8



    $       1,717.5



    $          1,634.8

















    Segment Profit















    Wet Shave

    $               32.1



    $               37.5



    $          102.6



    $             116.6

    Sun and Skin Care

    61.1



    46.6



    114.1



    92.6

    Feminine Care

    13.9



    8.8



    37.7



    19.1

    Total segment profit

    107.1



    92.9



    254.4



    228.3

    General corporate and other expenses

    (15.8)



    (14.8)



    (48.7)



    (42.8)

    Amortization of intangibles

    (7.8)



    (7.8)



    (23.2)



    (21.8)

    Interest and other expense, net

    (15.4)



    (13.6)



    (53.3)



    (43.8)

    Restructuring and related costs

    (3.1)



    (3.9)



    (8.9)



    (9.8)

    Acquisition and integration costs

    (1.0)



    (0.9)



    (5.1)



    (8.0)

    Sun Care reformulation costs

    (0.6)



    (0.6)



    (1.7)



    (4.1)

    Defined benefit settlement loss

    —



    —



    (7.2)



    —

    VAT settlement costs

    —



    —



    —



    (3.4)

    Legal matters, net income (expense)

    6.8



    7.5



    6.3



    7.5

    SKU rationalization charges

    —



    (22.5)



    —



    (22.5)

    Total earnings before income taxes

    $               70.2



    $               36.3



    $          112.6



    $               79.6

    Refer to Note 2 GAAP to Non-GAAP Reconciliations for the income statement location of non-GAAP adjustments to earnings before income taxes.

    Note 2 — GAAP to Non-GAAP Reconciliations

    The following tables provide a GAAP to Non-GAAP reconciliation of certain line items from the Condensed Consolidated Statement of Earnings:



    Three Months Ended June 30, 2023



    Gross Profit



    SG&A



    Operating

    Income



    EBIT



    Income

    taxes



    Net

    Earnings



    Diluted EPS

    GAAP — Reported

    $       279.7



    $        96.3



    $        85.6



    $        70.2



    $        17.7



    $        52.5



    $          1.01

    Restructuring and related costs

    —



    0.1



    3.1



    3.1



    0.8



    2.3



    0.04

    Acquisition and integration costs

    —



    1.0



    1.0



    1.0



    0.2



    0.8



    0.02

    Sun Care reformulation costs

    —



    —



    0.6



    0.6



    0.2



    0.4



    0.01

    Legal matters, net (income) expense

    —



    (6.8)



    (6.8)



    (6.8)



    (1.6)



    (5.2)



    (0.10)

    Total Adjusted Non-GAAP

    $       279.7



    $      102.0



    $        83.5



    $        68.1



    $        17.3



    $        50.8



    $          0.98











































    Adjusted Non-GAAP Constant Currency



    $          1.07





























    GAAP as a percent of net sales

    43.0 %



    14.8 %



    13.2 %



    GAAP effective tax rate

    25.3 %





    Adjusted as a percent of net sales

    43.0 %



    15.7 %



    12.8 %



    Adjusted effective tax rate

    25.3 %





    Adjusted Constant Currency as a percent of net sales

    44.0 %







    13.8 %

















     



    Three Months Ended June 30, 2022



    Gross Profit



    SG&A



    Operating

    Income



    EBIT



    Income

    taxes



    Net

    Earnings



    Diluted EPS

    GAAP — Reported

    $      240.6



    $       92.7



    $       49.9



    $          36.3



    $            5.8



    $       30.5



    $          0.57

    Restructuring and related costs

    —



    0.4



    3.9



    3.9



    0.9



    3.0



    0.06

    Acquisition and integration costs

    —



    0.9



    0.9



    0.9



    0.3



    0.6



    0.01

    SKU rationalization charges

    22.5



    —



    22.5



    22.5



    5.5



    17.0



    0.32

    Sun Care reformulation costs

    —



    —



    0.6



    0.6



    0.2



    0.4



    0.01

    Legal matters, net (income) expense

    —



    (7.5)



    (7.5)



    (7.5)



    (1.8)



    (5.7)



    (0.11)

    Total Adjusted Non-GAAP

    $      263.1



    $       98.9



    $       70.3



    $          56.7



    $          10.9



    $       45.8



    $          0.86





























    GAAP as a percent of net sales

    38.6 %



    14.9 %



    8.0 %



    GAAP effective tax rate

    16.1 %





    Adjusted as a percent of net sales

    42.2 %



    15.9 %



    11.3 %



    Adjusted effective tax rate

    19.3 %





     



    Nine Months Ended June 30, 2023



    Gross Profit



    SG&A



    Operating

    Income



    EBIT



    Income

    taxes



    Net

    Earnings



    Diluted EPS

    GAAP — Reported

    $     710.4



    $     297.2



    $     173.1



    $        112.6



    $          29.2



    $       83.4



    $          1.61

    Restructuring and related costs

    0.2



    0.2



    9.1



    9.1



    2.4



    6.7



    0.13

    Acquisition and integration costs

    —



    5.1



    5.1



    5.1



    1.2



    3.9



    0.08

    Sun Care reformulation costs

    —



    —



    1.7



    1.7



    0.4



    1.3



    0.02

    Defined benefit settlement loss

    —



    —



    —



    7.2



    1.9



    5.3



    0.10

    Legal matters, net (income) expense

    —



    (6.3)



    (6.3)



    (6.3)



    (1.5)



    (4.8)



    (0.09)

    Total Adjusted Non-GAAP

    $     710.6



    $     298.2



    $     182.7



    $        129.4



    $          33.6



    $       95.8



    $          1.85











































    Adjusted Non-GAAP Constant Currency



    $          2.13





























    GAAP as a percent of net sales

    41.4 %



    17.3 %



    10.1 %



    GAAP effective tax rate

    25.9 %





    Adjusted as a percent of net sales

    41.4 %



    17.4 %



    10.6 %



    Adjusted effective tax rate

    25.9 %





    Adjusted Constant Currency as a percent of net sales

    42.4 %







    11.7 %

















     



    Nine Months Ended June 30, 2022



    Gross Profit



    SG&A



    Operating

    Income



    EBIT



    Income

    taxes



    Net

    Earnings



    Diluted EPS

    GAAP — Reported

    $      660.6



    $      290.9



    $     123.4



    $          79.6



    $          14.7



    $        64.9



    $          1.20

    Restructuring and related costs

    —



    0.6



    9.8



    9.8



    2.5



    7.3



    0.14

    Acquisition and integration costs

    0.8



    7.2



    8.0



    8.0



    0.8



    7.2



    0.13

    Sun Care reformulation costs

    3.5



    —



    4.1



    4.1



    1.1



    3.0



    0.06

    VAT settlement costs

    —



    3.4



    3.4



    3.4



    1.1



    2.3



    0.04

    Legal matters, net (income) expense

    —



    (7.5)



    (7.5)



    (7.5)



    (1.8)



    (5.7)



    (0.11)

    SKU rationalization charges

    22.5



    —



    22.5



    22.5



    5.5



    17.0



    0.31

    Total Adjusted Non-GAAP

    $      687.4



    $      287.2



    $     163.7



    $        119.9



    $          23.9



    $        96.0



    $          1.77





























    GAAP as a percent of net sales

    40.4 %



    17.8 %



    7.5 %



    GAAP effective tax rate

    18.5 %





    Adjusted as a percent of net sales

    42.0 %



    17.6 %



    10.0 %



    Adjusted effective tax rate

    20.0 %





    Note 3 - Net Sales and Profit by Segment

    Operations for the Company are reported via three Segments. The impact of acquisition includes the operations of Billie which was acquired in November 2021. The following tables present changes in net sales and segment profit for the third quarter and first nine months ended June 30, 2023, as compared to the corresponding period in the prior quarter.

    Net Sales

    Quarter Ended June 30, 2023



    Wet

    Shave



    Sun and Skin

    Care



    Feminine

    Care



    Total

    Net Sales - Q3 FY22

    $   326.3







    $   216.2







    $     81.3







    $   623.8





    Organic

    (0.2)



    (0.1) %



    28.1



    13.0 %



    —



    — %



    27.9



    4.5 %

    Impact of currency

    (2.0)



    (0.6) %



    0.6



    0.3 %



    (0.3)



    (0.4) %



    (1.7)



    (0.3) %

    Net Sales - Q3 FY23

    $   324.1



    (0.7) %



    $   244.9



    13.3 %



    $     81.0



    (0.4) %



    $   650.0



    4.2 %

     

    Net Sales

    Nine Months Ended June 30, 2023



    Wet

    Shave



    Sun and Skin

    Care



    Feminine

    Care



    Total

    Net Sales - Q3 FY22

    $   917.4







    $   504.3







    $   213.1







    $ 1,634.8





    Organic

    8.1



    0.9 %



    66.6



    13.2 %



    29.7



    13.9 %



    104.4



    6.4 %

    Impact of Billie acquisition, net

    12.0



    1.3 %



    —



    — %



    —



    — %



    12.0



    0.7 %

    Impact of currency

    (29.5)



    (3.2) %



    (3.4)



    (0.7) %



    (0.8)



    (0.4) %



    (33.7)



    (2.1) %

    Net Sales - Q3 FY23

    $   908.0



    (1.0) %



    $   567.5



    12.5 %



    $   242.0



    13.5 %



    $ 1,717.5



    5.0 %

































    Organic net sales were impacted in the first quarter of fiscal 2023 by the change in classification of sales from third party to intercompany as a result of the Billie acquisition in fiscal 2022. The impact of the Billie acquisition, net is calculated as Billie net third party sales from October 1, 2022 through November 30, 2022 less sales to Billie by the Company in the comparable prior year period, which totaled $12.3.

    Segment Profit

    Quarter Ended June 30, 2023



    Wet

    Shave



    Sun and Skin

    Care



    Feminine

    Care



    Total

    Segment Profit - Q3 FY22

    $     37.5







    $     46.6







    $       8.8







    $     92.9





    Organic

    1.2



    3.2 %



    14.7



    31.5 %



    5.2



    59.1 %



    21.1



    22.7 %

    Impact of currency

    (6.6)



    (17.6) %



    (0.2)



    (0.4) %



    (0.1)



    (1.1) %



    (6.9)



    (7.4) %

    Segment Profit - Q3 FY23

    $     32.1



    (14.4) %



    $     61.1



    31.1 %



    $     13.9



    58.0 %



    $   107.1



    15.3 %

     

    Segment Profit

    Nine Months Ended June 30, 2023



    Wet

    Shave



    Sun and Skin

    Care



    Feminine

    Care



    Total

    Segment Profit - Q3 FY22

    $   116.6







    $     92.6







    $     19.1







    $   228.3





    Organic

    7.6



    6.5 %



    22.4



    24.2 %



    19.3



    101.0 %



    49.3



    21.6 %

    Impact of currency

    (21.6)



    (18.5) %



    (0.9)



    (1.0) %



    (0.7)



    (3.7) %



    (23.2)



    (10.2) %

    Segment Profit - Q3 FY23

    $   102.6



    (12.0) %



    $   114.1



    23.2 %



    $     37.7



    97.3 %



    $   254.4



    11.4 %

    For all tables, the impact of currency to segment profit includes both the translational and transactional currency changes during the quarter.

    Note 4 - Net Debt and EBITDA

    The Company reports financial results on a GAAP and adjusted basis. The tables below are used to reconcile Net Debt and Net earnings to EBITDA and Adjusted EBITDA, which are Non-GAAP measures, to improve comparability of results between periods.



    June 30,

    2023



    September 30,

    2022

    Notes payable

    $                 17.7



    $                 19.0

    Long-term debt

    1,323.1



    1,391.4

    Gross debt

    $            1,340.8



    $            1,410.4

    Less: Cash and cash equivalents

    207.4



    188.7

    Net Debt

    $            1,133.4



    $            1,221.7

     



    Three Months Ended

    June 30,



    Nine Months Ended

    June 30,



    2023



    2022



    2023



    2022

    Net earnings

    $                 52.5



    $                 30.5



    $                 83.4



    $                 64.9

    Income tax provision

    17.7



    5.8



    29.2



    14.7

    Interest expense, net

    18.5



    17.8



    58.5



    53.4

    Depreciation and amortization

    22.5



    22.6



    68.1



    67.1

    EBITDA

    $               111.2



    $                 76.7



    $               239.2



    $               200.1

















    Restructuring and related costs

    3.1



    3.9



    9.1



    9.8

    Acquisition and integration costs

    1.0



    0.9



    5.1



    8.0

    Sun Care reformulation costs

    0.6



    0.6



    1.7



    4.1

    Defined benefit settlement

    —



    —



    7.2



    —

    VAT settlement costs

    —



    —



    —



    3.4

    Legal matters, net (income) expense

    (6.8)



    (7.5)



    (6.3)



    (7.5)

    SKU rationalization charges

    —



    22.5



    —



    22.5

    Adjusted EBITDA

    $               109.1



    $                 97.1



    $               256.0



    $               240.4

















    Adjusted EBITDA Constant Currency

    $               114.5







    $               275.4





    Note 5 - Outlook

    The following tables provide reconciliations of Adjusted EPS and Adjusted EBITDA, Non-GAAP measures, included within the Company's outlook for projected fiscal 2023 results:

    Adjusted EPS Outlook





    Fiscal 2023 GAAP EPS



    $1.95 - $2.15







    Restructuring and related costs

    approx.

    0.36

    Acquisition and integration costs

    approx.

    0.12

    Defined benefit settlement loss

    approx.

    0.14

    Legal matters, net (income) expense

    approx.

    (0.14)

    Sun Care reformulation costs

    approx.

    0.06

    Other costs

    approx.

    0.02

    Income taxes(1)

    approx.

    (0.14)







    Fiscal 2023 Adjusted EPS Outlook (Non-GAAP)



    $2.30 - $2.50



         (1)  Income tax effect of the adjustments to Fiscal 2023 GAAP EPS noted above.



    Adjusted EBITDA Outlook





    Fiscal 2023 GAAP Net Income

    approx.

    $100 - $115

    Income tax provision

    approx.

    35

    Interest expense, net

    approx.

    77

    Depreciation and amortization

    approx.

    90

    EBITDA

    approx.

    $302 - $317







    Restructuring and related costs

    approx.

    18

    Acquisition and integration costs

    approx.

    6

    Defined benefit settlement loss

    approx.

    7

    Legal matters, net (income) expense

    approx.

    (7)

    Sun Care reformulation costs

    approx.

    3

    Other costs

    approx.

    1

    Fiscal 2023 Adjusted EBITDA

    approx.

    $320 - $335

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2023-results-301892187.html

    SOURCE Edgewell Personal Care Company

    Get the next $EPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EPC

    DatePrice TargetRatingAnalyst
    8/6/2025$23.00Underweight → Equal-Weight
    Morgan Stanley
    2/8/2024$39.00Underweight → Equal Weight
    Barclays
    4/5/2023$47.00Neutral
    UBS
    11/17/2022$48.00Buy
    Canaccord Genuity
    10/26/2022$47.00 → $42.00Buy → Neutral
    Goldman
    10/17/2022$40.00 → $36.00Equal-Weight → Underweight
    Morgan Stanley
    2/10/2022$46.00 → $43.00Equal-Weight
    Morgan Stanley
    2/9/2022$55.00 → $47.00Overweight
    Wells Fargo
    More analyst ratings

    $EPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sit Swan

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:50:21 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by Director Sachdev Rakesh

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:49:26 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by Director Stahl Stephanie

    4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

    2/9/26 10:48:33 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Edgewell Personal Care Company

    SCHEDULE 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/12/26 5:17:21 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-Q filed by Edgewell Personal Care Company

    10-Q - EDGEWELL PERSONAL CARE Co (0001096752) (Filer)

    2/9/26 1:35:34 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Company filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - EDGEWELL PERSONAL CARE Co (0001096752) (Filer)

    2/9/26 6:34:55 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Edgewell Personal Care upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Edgewell Personal Care from Underweight to Equal-Weight and set a new price target of $23.00

    8/6/25 7:51:55 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care upgraded by Barclays with a new price target

    Barclays upgraded Edgewell Personal Care from Underweight to Equal Weight and set a new price target of $39.00

    2/8/24 6:30:53 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    UBS initiated coverage on Edgewell Personal Care with a new price target

    UBS initiated coverage of Edgewell Personal Care with a rating of Neutral and set a new price target of $47.00

    4/5/23 8:58:06 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edgewell Personal Care to Webcast Fireside Chat at the 47th Annual Raymond James Institutional Investors Conference

    SHELTON, Conn., Feb. 27, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced that it will participate in a fireside chat at the 47th Annual Raymond James Institutional Investors Conference in Orlando, FL on Wednesday March 4, 2026, at 8:40 A.M. ET.  Rod Little, President and Chief Executive Officer and Francesca Weissman, Chief Financial Officer will be presenting for Edgewell. All interested parties may access a live webcast of these events at www.edgewell.com, under "Investors," and "News and Events" tabs or by using the following link:  http://ir.ed

    2/27/26 12:32:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces First Quarter Fiscal 2026 Results

    Q1 performance ahead of expectations for Sales, Adjusted EPS and EBITDA Successfully Completed Feminine Care Business Divestiture for $340 Million, Sharpening Portfolio Focus Full Year Outlook for Continuing Operations Remains Consistent with Prior Outlook SHELTON, Conn., Feb. 9, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its first fiscal quarter 2026 ended December 31, 2025.  "We delivered a solid start to fiscal 2026. Our first quarter performance modestly exceeded our expectations for organic net sales, adjusted EPS and adjus

    2/9/26 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Completes the Sale of its Feminine Care Business to Essity for $340M

    SHELTON, Conn., Feb. 2, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced that it has completed the sale of its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for $340 million. Edgewell intends to use the net proceeds from the sale, after taxes and transaction costs, primarily to strengthen its balance sheet and pay down the balance of U.S. revolving credit facility while continuing to invest in the long-term growth of its core businesses. "Completing the sale of our Feminine Care business is a pivota

    2/2/26 12:16:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Edgewell Personal Care Company

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    11/8/24 10:55:54 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/13/24 5:04:49 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

    SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/12/24 11:09:25 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Leadership Updates

    Live Leadership Updates

    View All

    Edgewell Personal Care Appoints Jessica Spence as President of North America Business

    SHELTON, Conn., Oct. 2, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) is pleased to announce the appointment of Jessica Spence as President of its North America business, effective October 24, 2024. In this role, Spence will lead Edgewell's North American commercial business and will report directly to Rod Little, President and Chief Executive Officer. Edgewell's President and Chief Executive Officer, Rod Little commented, "We are thrilled to welcome Jessica to our team. Jessica is a seasoned and accomplished leader with an impressive brand-building and opera

    10/2/24 10:27:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Appoints Stephanie Stahl to Board of Directors

    SHELTON, Conn., Sept. 12, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) announced that it has appointed Stephanie Stahl to its Board of Directors, effective September 10. Following her appointment, the Board will now include 11 members. As a consumer-driven and sustainability-focused business leader, brand builder, board member and advisor, Stahl has extensive marketing and strategy experience in high-growth, turnaround and early-stage operating environments. She also has significant business transformation, post-merger integration and public board leadership

    9/12/24 1:08:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces Appointment of John Dunham as Chief Accounting Officer

    SHELTON, Conn., Feb. 23, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced the appointment of John Dunham as Chief Accounting Officer (CAO). Mr. Dunham will be based in the Company's Shelton, Connecticut office reporting to Dan Sullivan, Chief Financial Officer. "John is a seasoned accounting executive with over twenty years of broad-based technical and operational accounting experience. During his career, he has demonstrated a track record of success in improving operational accounting effectiveness and regulatory compliance as well as developing

    2/23/24 8:30:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    $EPC
    Financials

    Live finance-specific insights

    View All

    Edgewell Personal Care Announces First Quarter Fiscal 2026 Results

    Q1 performance ahead of expectations for Sales, Adjusted EPS and EBITDA Successfully Completed Feminine Care Business Divestiture for $340 Million, Sharpening Portfolio Focus Full Year Outlook for Continuing Operations Remains Consistent with Prior Outlook SHELTON, Conn., Feb. 9, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its first fiscal quarter 2026 ended December 31, 2025.  "We delivered a solid start to fiscal 2026. Our first quarter performance modestly exceeded our expectations for organic net sales, adjusted EPS and adjus

    2/9/26 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Company to Webcast a Discussion of First Quarter Fiscal Year 2026 Results on February 9, 2026

    SHELTON, Conn., Jan. 12, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) will report its financial results for the first quarter fiscal year 2026 before the market opens on February 9, 2026. Edgewell will discuss its results during an investor conference call that will be webcast on February 9, 2026, beginning at 8:00 a.m. Eastern Time. The call will be hosted by President and Chief Executive Officer Rod Little and Chief Financial Officer Francesca Weissman. All interested parties may access a live webcast of this conference call at www.edgewell.com, under "Inve

    1/12/26 4:30:00 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Edgewell Personal Care Announces Fourth Quarter and Fiscal 2025 Results; Provides 2026 Outlook

    Fourth Quarter Net Sales increased 3.8%, or 2.5% Organic increaseFiscal 2025 Net Sales decreased 1.3%, or 1.3% Organic decreaseFiscal 2025 GAAP EPS $0.53, Adjusted EPS $2.52 Returned $120 Million to Shareholders via Dividends and Share Repurchases for Fiscal Year 2025 SHELTON, Conn., Nov. 13, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its fourth fiscal quarter 2025 and fiscal year ended September 30, 2025.  Executive Summary Fourth quarter net sales were $537.2 million, an increase of 3.8% compared to the prior year quarter. Ful

    11/13/25 6:00:00 AM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary